vs

Side-by-side financial comparison of ROCKWELL MEDICAL, INC. (RMTI) and Stran & Company, Inc. (SWAG). Click either name above to swap in a different company.

Stran & Company, Inc. is the larger business by last-quarter revenue ($28.9M vs $18.3M, roughly 1.6× ROCKWELL MEDICAL, INC.). Stran & Company, Inc. runs the higher net margin — 0.8% vs -3.0%, a 3.9% gap on every dollar of revenue. On growth, Stran & Company, Inc. posted the faster year-over-year revenue change (7.2% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $38.0K). Over the past eight quarters, Stran & Company, Inc.'s revenue compounded faster (24.0% CAGR vs -10.1%).

Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).

Stran & Company, Inc. provides branded promotional products, custom merchandise and integrated marketing solutions for corporate clients. It serves customers across retail, healthcare, technology, education and other sectors, supporting brand campaigns, customer engagement and employee incentive programs.

RMTI vs SWAG — Head-to-Head

Bigger by revenue
SWAG
SWAG
1.6× larger
SWAG
$28.9M
$18.3M
RMTI
Growing faster (revenue YoY)
SWAG
SWAG
+32.8% gap
SWAG
7.2%
-25.6%
RMTI
Higher net margin
SWAG
SWAG
3.9% more per $
SWAG
0.8%
-3.0%
RMTI
More free cash flow
RMTI
RMTI
$2.2M more FCF
RMTI
$2.2M
$38.0K
SWAG
Faster 2-yr revenue CAGR
SWAG
SWAG
Annualised
SWAG
24.0%
-10.1%
RMTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RMTI
RMTI
SWAG
SWAG
Revenue
$18.3M
$28.9M
Net Profit
$-554.0K
$243.0K
Gross Margin
21.1%
30.4%
Operating Margin
-2.2%
-0.1%
Net Margin
-3.0%
0.8%
Revenue YoY
-25.6%
7.2%
Net Profit YoY
26.7%
141.5%
EPS (diluted)
$-0.01
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMTI
RMTI
SWAG
SWAG
Q4 25
$18.3M
$28.9M
Q3 25
$15.9M
$26.0M
Q2 25
$16.1M
$32.6M
Q1 25
$18.9M
$28.7M
Q4 24
$24.7M
$27.0M
Q3 24
$28.3M
$20.1M
Q2 24
$25.8M
$16.7M
Q1 24
$22.7M
$18.8M
Net Profit
RMTI
RMTI
SWAG
SWAG
Q4 25
$-554.0K
$243.0K
Q3 25
$-1.8M
$-1.2M
Q2 25
$-1.5M
$643.0K
Q1 25
$-1.5M
$-393.0K
Q4 24
$-756.0K
$-586.0K
Q3 24
$1.7M
$-2.0M
Q2 24
$343.0K
$-1.0M
Q1 24
$-1.7M
$-491.0K
Gross Margin
RMTI
RMTI
SWAG
SWAG
Q4 25
21.1%
30.4%
Q3 25
14.3%
27.2%
Q2 25
15.6%
30.3%
Q1 25
16.1%
29.6%
Q4 24
14.7%
32.5%
Q3 24
22.0%
29.5%
Q2 24
17.6%
32.8%
Q1 24
13.5%
29.8%
Operating Margin
RMTI
RMTI
SWAG
SWAG
Q4 25
-2.2%
-0.1%
Q3 25
-9.9%
-6.9%
Q2 25
-8.4%
1.2%
Q1 25
-7.2%
-1.9%
Q4 24
-2.1%
-3.5%
Q3 24
6.8%
-10.8%
Q2 24
2.0%
-6.6%
Q1 24
-5.8%
-3.5%
Net Margin
RMTI
RMTI
SWAG
SWAG
Q4 25
-3.0%
0.8%
Q3 25
-11.0%
-4.8%
Q2 25
-9.3%
2.0%
Q1 25
-8.0%
-1.4%
Q4 24
-3.1%
-2.2%
Q3 24
5.9%
-10.1%
Q2 24
1.3%
-6.1%
Q1 24
-7.6%
-2.6%
EPS (diluted)
RMTI
RMTI
SWAG
SWAG
Q4 25
$-0.01
$0.02
Q3 25
$-0.05
$-0.07
Q2 25
$-0.05
$0.03
Q1 25
$-0.04
$-0.02
Q4 24
$-0.02
$-0.02
Q3 24
$0.04
$-0.11
Q2 24
$0.01
$-0.06
Q1 24
$-0.06
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMTI
RMTI
SWAG
SWAG
Cash + ST InvestmentsLiquidity on hand
$10.7M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$37.0M
$30.5M
Total Assets
$57.1M
$49.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMTI
RMTI
SWAG
SWAG
Q4 25
$10.7M
$11.6M
Q3 25
$13.6M
$11.8M
Q2 25
$12.5M
$18.1M
Q1 25
$11.4M
$12.2M
Q4 24
$15.7M
$18.2M
Q3 24
$12.3M
$6.9M
Q2 24
$11.9M
$9.6M
Q1 24
$6.6M
$10.7M
Stockholders' Equity
RMTI
RMTI
SWAG
SWAG
Q4 25
$37.0M
$30.5M
Q3 25
$37.0M
$30.2M
Q2 25
$30.4M
$31.8M
Q1 25
$31.5M
$31.3M
Q4 24
$32.6M
$31.6M
Q3 24
$29.1M
$32.3M
Q2 24
$23.5M
$34.3M
Q1 24
$20.6M
$35.2M
Total Assets
RMTI
RMTI
SWAG
SWAG
Q4 25
$57.1M
$49.3M
Q3 25
$57.5M
$50.3M
Q2 25
$52.6M
$61.2M
Q1 25
$54.0M
$52.2M
Q4 24
$59.2M
$55.1M
Q3 24
$57.1M
$48.8M
Q2 24
$53.0M
$46.6M
Q1 24
$50.7M
$47.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMTI
RMTI
SWAG
SWAG
Operating Cash FlowLast quarter
$2.3M
$161.0K
Free Cash FlowOCF − Capex
$2.2M
$38.0K
FCF MarginFCF / Revenue
12.0%
0.1%
Capex IntensityCapex / Revenue
0.5%
0.4%
Cash ConversionOCF / Net Profit
0.66×
TTM Free Cash FlowTrailing 4 quarters
$-1.2M
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMTI
RMTI
SWAG
SWAG
Q4 25
$2.3M
$161.0K
Q3 25
$-1.3M
$-5.4M
Q2 25
$1.8M
$6.4M
Q1 25
$-3.5M
$-5.9M
Q4 24
$865.0K
$1.3M
Q3 24
$4.3M
$-2.7M
Q2 24
$1.4M
$2.1M
Q1 24
$-2.4M
$2.1M
Free Cash Flow
RMTI
RMTI
SWAG
SWAG
Q4 25
$2.2M
$38.0K
Q3 25
$-1.5M
$-5.9M
Q2 25
$1.7M
$6.3M
Q1 25
$-3.5M
$-6.0M
Q4 24
$470.0K
$1.2M
Q3 24
$4.1M
$-2.9M
Q2 24
$1.2M
$1.9M
Q1 24
$-2.5M
$1.9M
FCF Margin
RMTI
RMTI
SWAG
SWAG
Q4 25
12.0%
0.1%
Q3 25
-9.6%
-22.6%
Q2 25
10.5%
19.5%
Q1 25
-18.8%
-21.0%
Q4 24
1.9%
4.6%
Q3 24
14.4%
-14.3%
Q2 24
4.5%
11.6%
Q1 24
-11.1%
9.9%
Capex Intensity
RMTI
RMTI
SWAG
SWAG
Q4 25
0.5%
0.4%
Q3 25
1.4%
1.9%
Q2 25
1.0%
0.2%
Q1 25
0.3%
0.4%
Q4 24
1.6%
0.3%
Q3 24
0.7%
0.7%
Q2 24
1.1%
1.1%
Q1 24
0.6%
1.0%
Cash Conversion
RMTI
RMTI
SWAG
SWAG
Q4 25
0.66×
Q3 25
Q2 25
9.99×
Q1 25
Q4 24
Q3 24
2.57×
Q2 24
4.20×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

SWAG
SWAG

Promotional Products Dropshipping$11.2M39%
Casino Continuity Program$6.9M24%
Promotional Products Company Owned Inventory$4.6M16%
Promotional Products Bulk Dropshipping$3.8M13%
Promotional Products Thirdparty Distributor$1.8M6%
Other$610.0K2%

Related Comparisons